Literature DB >> 14695896

Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells.

Eugenia Cifuentes1, Jennifer M Mataraza, Barbara A Yoshida, Mani Menon, David B Sacks, Evelyn R Barrack, G Prem-Veer Reddy.   

Abstract

Ca(2+) and calmodulin (CaM) play a critical role in proliferation and viability of a wide variety of cells, including prostate cancer cells. We examined two prostate cancer cell lines, androgen-sensitive LNCaP and androgen-independent PC-3. Proliferation of LNCaP cells was six to eight times more sensitive to the inhibitory effect of the CaM antagonist N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) than were PC-3 cells. Because LNCaP cell proliferation is sensitive to stimulation by androgen, we assessed the physical and functional interaction between androgen receptor (AR) and CaM. We observed tight binding of AR to CaM when LNCaP cell extracts were subjected to CaM-affinity column chromatography. AR binding to CaM was Ca(2+)-dependent and was inhibited by pretreatment of the cell extracts with W-7. Using immunofluorescence staining and confocal microscopy, we demonstrated colocalization of AR and CaM in the nucleus of LNCaP cells. Furthermore, the functional relevance of AR-CaM interactions in intact cells was revealed by the observation that W-7 was as effective as Casodex, an antiandrogen, in blocking AR-regulated expression of prostate-specific antigen in LNCaP cells. AR seems to interact with CaM directly because purified human AR could bind to CaM-agarose, and CaM could be detected in AR-immunoprecipitate prepared from purified soluble proteins. These studies provide direct evidence for physical and functional interaction between AR and CaM and suggest the potential usefulness of CaM antagonists in blocking AR activity in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695896      PMCID: PMC327170          DOI: 10.1073/pnas.0307161101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Calmodulin enhances the stability of the estrogen receptor.

Authors:  Z Li; J L Joyal; D B Sacks
Journal:  J Biol Chem       Date:  2001-02-15       Impact factor: 5.157

2.  Cyclic nucleotide phosphodiesterases in neoplastic and nonneoplastic human mammary tissues.

Authors:  A L Singer; R P Sherwin; A S Dunn; M M Appleman
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

3.  Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions.

Authors:  C J Loy; K S Sim; E L Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

4.  Catalytic function of thymidylate synthase is confined to S phase due to its association with replitase.

Authors:  G Prem veer Reddy
Journal:  Biochem Biophys Res Commun       Date:  1982-12-15       Impact factor: 3.575

5.  Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.

Authors:  Mujib M Rahman; Hiroshi Miyamoto; Henry Lardy; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

6.  Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.

Authors:  H Y Lam
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

7.  Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13.

Authors:  J W Wei; R A Hickie; D J Klaassen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

8.  N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

Authors:  H Hidaka; Y Sasaki; T Tanaka; T Endo; S Ohno; Y Fujii; T Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF.

Authors:  James Reid; Ian Murray; Kate Watt; Russell Betney; Iain J McEwan
Journal:  J Biol Chem       Date:  2002-08-13       Impact factor: 5.157

Review 10.  Endocrine-induced regression of cancers.

Authors:  C Huggins
Journal:  Science       Date:  1967-05-26       Impact factor: 47.728

View more
  16 in total

1.  Genome-wide screening of indicator genes for assessing the potential carcinogenic risk of Nanjing city drinking water.

Authors:  Rui Zhang; Shupei Cheng; Aimin Li; Jie Sun; Yan Zhang; Xuxiang Zhang
Journal:  Ecotoxicology       Date:  2011-03-22       Impact factor: 2.823

2.  Exploring the dynamics of cell processes through simulations of fluorescence microscopy experiments.

Authors:  Juan Angiolini; Nicolas Plachta; Esteban Mocskos; Valeria Levi
Journal:  Biophys J       Date:  2015-06-02       Impact factor: 4.033

3.  Androgen receptor interacts with telomeric proteins in prostate cancer cells.

Authors:  Sahn-Ho Kim; Michelle Richardson; Kannagi Chinnakannu; V Uma Bai; Mani Menon; Evelyn R Barrack; G Prem-Veer Reddy
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

Review 4.  Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease.

Authors:  S M Cabarcas; E M Hurt; W L Farrar
Journal:  Curr Mol Med       Date:  2010-11       Impact factor: 2.222

5.  Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells.

Authors:  Arun Sivanandam; Shalini Murthy; Kannagi Chinnakannu; V Uma Bai; Sahn-Ho Kim; Evelyn R Barrack; Mani Menon; G Prem-Veer Reddy
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

6.  A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.

Authors:  Loukia G Karacosta; Barbara A Foster; Gissou Azabdaftari; David M Feliciano; Arthur M Edelman
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

Review 7.  The Potential Role of Exosomal Proteins in Prostate Cancer.

Authors:  Shangzhi Feng; Kecheng Lou; Xiaofeng Zou; Junrong Zou; Guoxi Zhang
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

8.  Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells.

Authors:  Huanjie Yang; Shalini Murthy; Fazlul H Sarkar; Shijie Sheng; G Prem-Veer Reddy; Q Ping Dou
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

9.  Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase.

Authors:  Shalini Murthy; Min Wu; V Uma Bai; Zizheng Hou; Mani Menon; Evelyn R Barrack; Sahn-Ho Kim; G Prem-Veer Reddy
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Small-molecule hormones: molecular mechanisms of action.

Authors:  Monika Puzianowska-Kuznicka; Eliza Pawlik-Pachucka; Magdalena Owczarz; Monika Budzińska; Jacek Polosak
Journal:  Int J Endocrinol       Date:  2013-02-28       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.